These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19946106)

  • 1. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.
    Tarantini G; Razzolini R; Napodano M; Bilato C; Ramondo A; Iliceto S
    Eur Heart J; 2010 Mar; 31(6):676-83. PubMed ID: 19946106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.
    Boersma E;
    Eur Heart J; 2006 Apr; 27(7):779-88. PubMed ID: 16513663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction.
    Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Grines CL; Aversano T; Concannon TW; Zalenski RJ; Selker HP
    Am J Cardiol; 2007 May; 99(10):1384-8. PubMed ID: 17493465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).
    Nielsen PH; Terkelsen CJ; Nielsen TT; Thuesen L; Krusell LR; Thayssen P; Kelbaek H; Abildgaard U; Villadsen AB; Andersen HR; Maeng M;
    Am J Cardiol; 2011 Sep; 108(6):776-81. PubMed ID: 21757183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction.
    Claeys MJ; de Meester A; Convens C; Dubois P; Boland J; De Raedt H; Vranckx P; Coussement P; Gevaert S; Sinnaeve P; Evrard P; Beauloye C; Renard M; Vrints C
    Arch Intern Med; 2011 Mar; 171(6):544-9. PubMed ID: 21444843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age.
    de Boer SP; Westerhout CM; Simes RJ; Granger CB; Zijlstra F; Boersma E;
    JACC Cardiovasc Interv; 2010 Mar; 3(3):324-31. PubMed ID: 20298993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies.
    Motovska Z; Widimsky P; Aschermann M;
    Heart; 2008 Mar; 94(3):e5. PubMed ID: 17693459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration.
    de Boer SP; Barnes EH; Westerhout CM; Simes RJ; Granger CB; Kastrati A; Widimsky P; de Boer MJ; Zijlstra F; Boersma E
    Am Heart J; 2011 Mar; 161(3):500-507.e1. PubMed ID: 21392604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    De Luca G; Biondi-Zoccai G; Marino P
    Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous coronary thrombolysis on evidence based reperfusion therapy for acute myocardial infarction].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():446-52. PubMed ID: 12735013
    [No Abstract]   [Full Text] [Related]  

  • 12. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction.
    Tarantini G; Razzolini R; Ramondo A; Napodano M; Bilato C; Iliceto S
    Am J Cardiol; 2005 Dec; 96(11):1503-5. PubMed ID: 16310430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined reperfusion strategies in ST-segment elevation MI: Rationale and current role.
    Hanna EB; Hennebry TA; Abu-Fadel MS
    Cleve Clin J Med; 2010 Sep; 77(9):629-38. PubMed ID: 20810873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time delay-adjusted survival benefit of angioplasty over thrombolysis in acute myocardial infarction: influence of time from symptom onset.
    Tarantini G; Ramondo A; Napodano M; Bilato C; Buja P; Isabella G; Razzolini R; Iliceto S
    Ital Heart J; 2004 Nov; 5(11):844-50. PubMed ID: 15633440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary angioplasty should be first line treatment for acute myocardial infarction: FOR.
    Smith D
    BMJ; 2004 May; 328(7450):1254-6. PubMed ID: 15155508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait? The risk-time relationship and the need to quantify the impact of delay.
    Tarantini G; Van de Werf F; Bilato C; Gersh B
    Am Heart J; 2011 Feb; 161(2):247-53. PubMed ID: 21315205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary care unit and primary percutaneous coronary intervention networks improve the standard of care: reperfusion therapy in ST elevation myocardial infarction in Serbia from 2002 to 2008.
    Vasiljevic Z; Mickovski-Katalina N; Krljanac G; Panic G; Putnikovic B; Ostojic M; Stojanovic B; Milanovic S
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):300-2. PubMed ID: 21386688
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to reperfusion in acute myocardial infarction. It is time to reduce it!
    Barbagelata A; Perna ER; Clemmensen P; Uretsky BF; Canella JP; Califf RM; Granger CB; Adams GL; Merla R; Birnbaum Y
    J Electrocardiol; 2007 Jul; 40(3):257-64. PubMed ID: 17478179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Smoker's paradox" and reperfusion's strategy in acute myocardial infarction].
    Addad F; Dridi Z; Jemmali M; Mzoughi K; Hassine M; Ghrissi I; Hamdi S; Mahjoub M; Betbout F; Ben Farhat M; Gamra H
    Ann Cardiol Angeiol (Paris); 2010 Aug; 59(4):183-9. PubMed ID: 20709314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.